These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 33140481)

  • 21. Cardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2.
    Buckley LF; Cheng JWM; Desai A
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):526-529. PubMed ID: 32301766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence.
    Turgeon RD; Zieroth S; Bewick D; Chow CM; Clarke B; Cowan S; Fordyce CB; Fournier A; Gin K; Gupta A; Hardiman S; Jackson S; Lau B; Leong-Poi H; Mansour S; Marelli A; Quraishi AR; Roifman I; Ruel M; Sapp J; Singh G; Small G; Virani S; Wood DA; Krahn A
    Can J Cardiol; 2020 Aug; 36(8):1180-1182. PubMed ID: 32502522
    [No Abstract]   [Full Text] [Related]  

  • 23. Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research.
    Omar MB
    Heart Lung; 2020; 49(4):351. PubMed ID: 32327200
    [No Abstract]   [Full Text] [Related]  

  • 24. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
    Gemmati D; Tisato V
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atrial fibrillation in COVID-19: A review of possible mechanisms.
    Stone E; Kiat H; McLachlan CS
    FASEB J; 2020 Sep; 34(9):11347-11354. PubMed ID: 33078484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association?
    Giollo A; Cioffi G; Rossini M; Viapiana O; De Simone G
    Eur J Intern Med; 2020 Oct; 80():106-107. PubMed ID: 32553588
    [No Abstract]   [Full Text] [Related]  

  • 27. Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.
    Murray E; Tomaszewski M; Guzik TJ
    Cardiovasc Res; 2020 Jun; 116(7):e87-e89. PubMed ID: 32301968
    [No Abstract]   [Full Text] [Related]  

  • 28. SARS-CoV-2 as a Factor to Disbalance the Renin-Angiotensin System: A Suspect in the Case of Exacerbated IL-6 Production.
    Franco R; Rivas-Santisteban R; Serrano-Marín J; Rodríguez-Pérez AI; Labandeira-García JL; Navarro G
    J Immunol; 2020 Sep; 205(5):1198-1206. PubMed ID: 32680957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renin-Angiotensin-Aldosterone System Inhibitors Impact on COVID-19 Mortality: What's Next for ACE2?
    Patel AB; Verma A
    Clin Infect Dis; 2020 Nov; 71(16):2129-2131. PubMed ID: 32442259
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID-19 and cardiovascular disease: characteristic features in older patients.
    Boureau AS; de Decker L; Berrut G; Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2020 Jun; 18(2):141-148. PubMed ID: 33064080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
    Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
    Front Immunol; 2020; 11():2014. PubMed ID: 32849666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
    Hrenak J; Simko F
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity and its impact on COVID-19.
    de Leeuw AJM; Oude Luttikhuis MAM; Wellen AC; Müller C; Calkhoven CF
    J Mol Med (Berl); 2021 Jul; 99(7):899-915. PubMed ID: 33824998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial.
    Ferreira JP; Girerd N; Rocca HB; Pellicori P; Cleland JG; Rossignol P; Zannad F
    Arch Cardiovasc Dis; 2021 Dec; 114(12):814-817. PubMed ID: 34772647
    [No Abstract]   [Full Text] [Related]  

  • 35. Natural infections of SARS-CoV-2 increased in animals: How should humans interact with animals?
    Zhai SL; Li CL; Sun MF; Zhang JF; Zheng C; Liao M
    J Med Virol; 2022 Aug; 94(8):3503-3505. PubMed ID: 35415911
    [No Abstract]   [Full Text] [Related]  

  • 36. Butyrate Regulates COVID-19-Relevant Genes in Gut Epithelial Organoids From Normotensive Rats.
    Li J; Richards EM; Handberg EM; Pepine CJ; Raizada MK
    Hypertension; 2021 Feb; 77(2):e13-e16. PubMed ID: 33439735
    [No Abstract]   [Full Text] [Related]  

  • 37. Granulomatous manifestations associated with COVID19 infection: Is there a link between these two diseases?
    Mertz P; Jeannel J; Guffroy A; Lescuyer S; Korganow AS; Rondeau-Lutz M; Weber JC
    Autoimmun Rev; 2021 Jun; 20(6):102824. PubMed ID: 33864942
    [No Abstract]   [Full Text] [Related]  

  • 38. Atrial Fibrillation in COVID-19: Therapeutic Target or Grave Omen?
    Khan H; Barbhaiya C
    Heart Lung Circ; 2021 Aug; 30(8):1114-1116. PubMed ID: 34215363
    [No Abstract]   [Full Text] [Related]  

  • 39. Atrial fibrillation is related to higher mortality in COVID-19/SARS-CoV-2 pneumonia infection.
    Denegri A; Morelli M; Pezzuto G; Malavasi VL; Boriani G
    Cardiol J; 2021; 28(6):973-975. PubMed ID: 34523114
    [No Abstract]   [Full Text] [Related]  

  • 40. Pre-admission atrial fibrillation in COVID-19 patients: Prevalence and clinical impact.
    Russo V; Silverio A; Scudiero F; Micco PD; Maio MD
    Eur J Intern Med; 2021 Jun; 88():133-135. PubMed ID: 33810938
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.